Access the full text.
Sign up today, get DeepDyve free for 14 days.
S. Barnes, T. Moffatt, R. Weiss (1950)
Demonstration of the L. E. Cell in the Absence of Anticoagulant1Journal of Investigative Dermatology, 14
Zimmer Fe, Hargraves Mm (1952)
The effect of blood coagulation on L.E. cell formation., 27
S. Holman (1951)
The Lupus Erythematosus Cell Inclusion PhenomenonJournal of Clinical Pathology, 4
A. V. Pisciotta , J. J. Giliberti, T. J. Greenwalt (1951)
Acute Hemolytic Anemia in Disseminate Lupus ErythematosusAm. J. Clin. Path., 21
M. Hargraves, H. Richmond, R. Morton (1948)
Presentation of two bone marrow elements; the tart cell and the L.E. cell.Proceedings of the staff meetings. Mayo Clinic, 23 2
L. Turner, J. Lansbury (1954)
LOW DIASTOLIC PRESSURE AS A CLINICAL FEATURE OF RHEUMATOID ARTHRITIS AND ITS POSSIBLE ETIOLOGIC SIGNIFICANCEThe American Journal of the Medical Sciences, 227
E. A. Brown (1953)
Drug AllergyQuart. Rev. Allergy, 7
M. F. Engman (1937)
Early Acute Lupus ErythematosusArch. Dermat. & Syph., 35
H. Perry, H. Schroeder (1954)
Syndrome simulating collagen disease caused by hydralazine (Apresoline).Journal of the American Medical Association, 154 8
H. Montgomery, W. McCreight (1949)
Disseminate lupus erythematosus.Archives of dermatology and syphilology, 60 3
M. Engman (1937)
LXXVII.—EARLY ACUTE LUPUS ERYTHEMATOSUSArchives of Dermatology, 35
E. Dubois (1952)
Acquired hemolytic anemias the presenting syndrome of lupus erythematosus disseminatus.The American journal of medicine, 12 2
A. Pisciotta, J. Giliberti, T. Greenwalt, W. Engstrom (1951)
Acute hemolytic anemia in disseminated lupus erythematosus; treatment with cortisone; report of case.American journal of clinical pathology, 21 12
L. Berman, A. Axelrod, H. Goodman, R. Mcclaughry (1950)
So-called "lupus erythematosus inclusion phenomenon" of bone marrow and blood.American journal of clinical pathology, 20 5
W. Hauser (1952)
Beobachtung des L. E.-ZellenPhänomens bei einer Kranken mit Senear-Usher SyndromHautartz, 3
J. Haserick (1951)
Simulation of the lupus erythematosus phenomenon by materials of fungal origin.The Journal of investigative dermatology, 16 4
M. Lincoln, W. Ricker (1954)
A case of periarteritis nodosa with L.E. cells; apparent complete remission with cortisone therapy.Annals of internal medicine, 41 3
J. Marshall, A. Zoutendyk, J. Gear (1951)
Serum auto-antibodies in diseases of the skin.South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 25 42
M. Hargraves (1954)
Systemic lupus erythematosus and L. E. cell phenomenon.Postgraduate medicine, 16 3
T. Magath, V. Winkle (1952)
Technic for demonstrating L. E. (lupus erythematosus) cells in blood.American journal of clinical pathology, 22 6
P. Miescher (1953)
Immunophagocytose des éléments cellulaires dans le sangJ. suisse méd., 9
L. J. Soffer , M. F. Levitt (1950)
Use of Cortisone and Adrenocorticotropic Hormone in Acute Disseminated Lupus ErythematosusArch. Int. Med., 86
S. Lee, S. Michael, I. Vural (1951)
The L.E. (lupus erythematosus) cell; clinical and chemical studies.The American journal of medicine, 10 4
D. Reinhardt, J. Waldron (1954)
Lupus erythematosus-like syndrome complicating hydralazine (apresoline) therapy.Journal of the American Medical Association, 155 17
A. Zoutendyk, J. Gear (1950)
Lupus Erythematosus—an Auto-antibody Disease?British Medical Journal, 2
P. Gausewitz, F. Jones, G. Worley (1951)
Fatal generalized moniliasis; report of a case.American journal of clinical pathology, 21 1
M. H. Stich , F. Feldman (1952)
Pre-L. E. Cell: A Stage in Development of the L. E. PhenomenonA. M. A. Arch. Dermat. & Syph., 65
L. Rasponi (1954)
Observations on the L. E. Phenomenon in Different Types of Lupus ErythematosusArch. ital. dermat. sif., 26
P. L. Gausewitz , F. S. Jones (1951)
Fatal Generalized MoniliasisAm. J. Clin. Path., 21
A. Paull (1955)
Occurrence of the L.E. phenomenon in a patient with a severe penicillin reaction.The New England journal of medicine, 252 4
N. H. Shackman , A. I. Swiller (1954)
Syndrome Simulating Acute Disseminated Lupus Erythematosus: Appearance After Hydralazine (Apresoline) TherapyJ. A. M. A., 155
John Walsh, Hyman Zimmerman (1953)
The demonstration of the L.E. phenomenon in patients with penicillin hypersensitivity.Blood, 8 1
H. M. Perry (1954)
Syndrome Simulating Collagen Disease Caused by Hydralazine (Apresoline)J. A. M. A., 154
N. Shackman, A. Swiller, M. Morrison (1954)
Syndrome simulating acute disseminated lupus erythematosus: appearance after hydralazine (apresoline) therapy.Journal of the American Medical Association, 155 17
S. Gold (1951)
Role of Sulphonamides and Penicillin in Pathogenesis of Systemic Lupus ErythematosusLancet, 1
Fisher Gs, Moyer Jb (1950)
Hematologic phenomena as a test for acute disseminated lupus erythematosus.The Grace Hospital bulletin, 28
D. J. Reinhardt (1954)
Lupus Erythematosus-like Syndrome Complicating Hydralazine (Apresoline) TherapyJ. A. M. A., 155
L. Meyler (1954)
Phagocytosis in Drug AllergyActa med. scandinav., 150
S. L. Lee , S. R. Michael (1951)
L. E. (Lupus Erythematosus) CellAm. J. Med., 10
M. Stich, F. Feldman, M. Morrison (1952)
Pre-L. E. cell; a stage in development of the L. E. phenomenon.A.M.A. archives of dermatology and syphilology, 65 5
H. P. Dustan , R. D. Taylor, A. C. Corcoran (1954)
Rheumatic and Febrile Syndrome During Prolonged Hydralazine TreatmentJ. A. M. A., 154
L. Soffer, M. Levitt, G. Baehr (1950)
Use of cortisone and adrenocorticotropic hormone in acute disseminated lupus erythematosus.A.M.A. archives of internal medicine, 86 4
H. Dustan, R. Taylor, A. Corcoran, I. Page (1954)
Rheumatic and febrile syndrome during prolonged hydralazine treatment.Journal of the American Medical Association, 154 1
Abstract Since the interesting discovery of the L. E. phenomenon by Hargraves and his co-workers,1 the diagnosis of systemic lupus erythematosus has been vastly facilitated and has been made in a number of hitherto obscure conditions. Moreover, certain cases of rheumatic and allied diseases have presented this blood picture, raising the question of whether or not this group of diseases is another manifestation of the etiologic agent which causes lupus erythematosus. Furthermore, the phenomenon has been reported in patients with drug allergies, and it has been suggested that the increase in the number of patients with lupus erythematous is due not only to more acute diagnosis and the rising interest in the disease, but also to the indiscriminate use of the sulfonamides and the antibiotics, especially penicillin. During the past year, we have examined a fairly large series of bloods from patients whose diseases References 1. References 11 to 14. 2. Saunders, J. C. (Ciba Pharmaceutical Products, Inc.): Personal communication to the authors. 3. Hargraves, M. M.: Personal communication to the authors. 4. Hagemann, P. O.: Personal communication to the authors. 5. References 29 and 30. 6. Hargraves, M. M.; Richmond, H., and Morton, R.: Presentation of Two Bone Marrow Elements: The "Tart" Cell and the "L. E." Cell , Proc. Staff Meet., Mayo Clin. 23:25, 1948. 7. Dubois, E. L.: Acquired Hemolytic Anemia as the Presenting Symptom of Lupus Erythematosus Disseminatus , Am. J. Med. 12:197, 1952.Crossref 8. Zimmer, F. E., and Hargraves, M. M.: The Effect of Blood Coagulation on L. E. Cell Formation , Proc. Staff Meet., Mayo Clin. 27:424, 1952. 9. Magath, T. B., and Winkle, V.: Technic for Demonstrating "L. E." (Lupus Erythematosus) Cells in Blood , Am. J. Clin. Path. 22:586, 1952. 10. Barnes, S. S.; Moffatt, T. W., and Weiss, R. S.: Demonstration of the L. E. Cell in the Absence of Anticoagulant , J. Invest. Dermat. 14: 397, 1950. 11. Walsh, J. R., and Zimmerman, H. J.: Demonstration of the L. E. Phenomenon in Patients with Penicillin Hypersensitivity , Blood 8:65, 1953. 12. Paull, A. M.: Occurrence of the L. E. Phenomenon in a Patient with a Severe Penicillin Reaction , New England J. Med. 252:128, 1955.Crossref 13. Brown, E. A.: Drug Allergy , Quart. Rev. Allergy 7:51, 1953. 14. Lincoln, M., and Ricker, W. A.: A Case of Periarteritis Nodosa with L. E. Cells: Apparent Complete Remission with Cortisone Therapy , Ann. Int. Med. 41:639, 1954.Crossref 15. Stich, M. H.; Feldman, F., and Morrison, M.: Pre-L. E. Cell: A Stage in Development of the L. E. Phenomenon , A. M. A. Arch. Dermat. & Syph. 65:581, 1952. 16. Dustan, H. P.; Taylor, R. D.; Corcoran, A. C., and Page, I. H.: Rheumatic and Febrile Syndrome During Prolonged Hydralazine Treatment , J. A. M. A. 154:23, 1954. 17. Perry, H. M., and Schroeder, H. A.: Syndrome Simulating Collagen Disease Caused by Hydralazine (Apresoline) , J. A. M. A. 154:670, 1954. 18. Reinhardt, D. J., and Waldron, J. M.: Lupus Erythematosus-like Syndrome Complicating Hydralazine (Apresoline) Therapy , J. A. M. A. 155: 1491, 1954. 19. Shackman, N. H.; Swiller, A. I., and Morrison, M.: Syndrome Simulating Acute Disseminated Lupus Erythematosus: Appearance After Hydralazine (Apresoline) Therapy , J. A. M. A. 155:1492, 1954. 20. Turner, L. W., and Lansbury, J.: Low Diastolic Pressure as a Clinical Feature of Rheumatoid Arthritis and its Possible Etiologic Significance , Am. J. Med. Sc. 227:503, 1954. 21. Meyler, L.: Phagocytosis in Drug Allergy , Acta med. scandinav. 150:33, 1954. 22. Hargraves, M. M.: Systemic Lupus Erythematosus and L. E. Cell Phenomenon , Postgrad. Med. 16:164, 1954. 23. Holman, S.: The Lupus Erythematosus Cell Inclusion Phenomenon , J. Clin. Path. 4:290, 1951. 24. Rasponi, L.: Observations on the L. E. Phenomenon in Different Types of Lupus Erythematosus , Arch. ital. dermat. sif. 26:121, 1954. 25. Haserick, J. R.: Simulation of the Lupus Erythematosus Phenomenon by Materials of Fungal Origin , J. Invest. Dermat. 16:211, 1951. 26. Soffer, L. J.; Levitt, M. F., and Baehr, G.: Use of Cortisone and Adrenocorticotropic Hormone in Acute Disseminated Lupus Erythematosus , Arch. Int. Med. 86:558, 1950.Crossref 27. Gausewitz, P. L.; Jones, F. S., and Worley, G.: Fatal Generalized Moniliasis , Am. J. Clin. Path. 21:41, 1951. 28. Hauser, W.: Beobachtung des L. E.-ZellenPhänomens bei einer Kranken mit Senear-Usher Syndrom , Hautartz 3:281, 1952. 29. Berman, L.; Axelrod, A. R.; Goodman, H. L., and McClaughry, R. I.: So-Called "Lupus Erythematosus Inclusion Phenomenon" of Bone Marrow and Blood , Am. J. Clin. Path. 20:403, 1950. 30. Mongomery, H., and McCreight, W. G.: Disseminate Lupus Erythematosus , Arch. Dermat. & Syph. 60:356, 1949. 31. Lee, S. L.; Michael, S. R., and Vural, I. L.: L. E. (Lupus Erythematosus) Cell , Am. J. Med. 10:446, 1951. 32. Fisher, G. S., and Moyer, J. B.: Hematologic Phenomena as a Test for Acute Disseminated Lupus Erythematosus , Grace Hosp. Bull. 28:3, 1950. 33. Miescher, P.: Immunophagocytose des éléments cellulaires dans le sang , J. suisse méd. 9:216, 1953. 34. Marshall, J.; Zoutendyk, A., and Gear, J.: Serum Auto-Antibodies in Diseases of the Skin , South African M. J. 25:764, 1951. 35. Zoutendyk, A., and Gear, J.: Lupus Erythematosus—An Auto-Antibody Disease? Brit. M. J. 2:1175, 1950. 36. Gold, S.: Role of Sulphonamides and Penicillin in Pathogenesis of Systemic Lupus Erythematosus , Lancet 1:268, 1951. 37. Pisciotta, A. V.; Giliberti, J. J.; Greenwalt, T. J., and Engstrom, W. W.: Acute Hemolytic Anemia in Disseminate Lupus Erythematosus , Am. J. Clin. Path. 21:1139, 1951. 38. Engman, M. F., Jr.: Early Acute Lupus Erythematosus , Arch. Dermat. & Syph. 35:685, 1937.
A.M.A. Archives of Dermatology – American Medical Association
Published: Aug 1, 1955
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.